Comparative Effectiveness Of MS Drugs, Biosimilars On PCORI’s Radar
This article was originally published in The Pink Sheet Daily
Executive Summary
Comparative effectiveness research for multiple sclerosis treatments will be discussed at an upcoming public workshop sponsored by the Patient-Centered Outcomes Research Institute. The organization is also adding biosimilars to its slate of possible research topics, according to Executive Director Selby.